Skip to content

iECG: Recording Chest Leads Using a Smartwatch With a Digital Image Processing Algorithm

iECG: A Feasibility Study for Recording Chest Leads Using a Smartwatch Coupled With a Digital Image Processing Algorithm

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05425342
Acronym
iECG
Enrollment
50
Registered
2022-06-21
Start date
2020-12-12
Completion date
2021-03-23
Last updated
2022-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Electrocardiogram

Keywords

Electrocardiogram ECG, Smartwatch ECG, Wearables, eHealth, medical image processing, machine learning, self health check-up, telemedicine, digital medicine, bipolar chest leads, electrical signal quality, self-recordable smartwatch ECG, heart rhythm, cardiac pathology in ECG

Brief summary

The purpose of this study is to evaluate the feasibility of a new method for self-recordable ECGs using a smartwatch coupled with an image processing algorithm. The long-term goal of this project is to establish such a method and to potentially integrate it into telemedical care.

Detailed description

There is an increasing availability of smartwatches worldwide. Health-related features of these wearables such as heart rate and -rhythm analysis have become increasingly recognised. Some smartwatches are capable of recording an electrocardiogram (ECG) which yields important information about electrical heart activity. Recording a complete ECG with a smartwatch is challenging if the user has no prior medical experience. In this feasibility study we introduce a novel image processing tool that instructs the user to record an ECG using the front camera of an iPad. In a second step, a standard ECG will be recorded by medical staff. The ECGs will then be compared by two board certified cardiologists. The aim of the study is to evaluate the feasibility of self-recorded smartwatch ECGs. If this method can be established, it could markedly expand the diagnostic options for heart and vascular diseases.

Interventions

DEVICESmartwatch ECG

Self-recorded 9-lead smartwatch ECGs

Sponsors

University of Basel
CollaboratorOTHER
University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Intervention model description

single group, open

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Participant ≥ 18 years * Ability to record a smartwatch ECG * Written informed consent as documented by signature from the participant

Exclusion criteria

* Smartwatch ECG or conventional ECG cannot be recorded due to comprehensible reasons (allergic reactions, wounds, etc.) * Unable or not willing to sign informed consent * Significant mental or cognitive impairment that could interfere with the measurements (e.g. delirium, acute psychotic episode, etc., assessed by recruiting physician) · Prior knowledge or experience in recording ECGs

Design outcomes

Primary

MeasureTime frameDescription
Correctly recorded smartwatch ECG lead by patient1 hourThe number of correctly recorded limb (I, II, III) and chest leads (bV1-bV6 where the letter b denotes bipolar chest leads) will be assessed. A correctly recorded lead is defined as a complete, 30-second long bipolar electrical signal obtained by the patient with the smartwatch afterpreviously being instructed. The number of correctly recorded smartwatch ECG leads is a measure to determine the feasibility of the method.

Secondary

MeasureTime frameDescription
Correctly identified chest lead position (V1-V6 vs. bV1-bV6)1 hourChest ECG leads obtained with a traditional ECG (V1-V6) will be compared with the ones recorded with a smartwatch (bV1-bV6). The percentage of correctly assigned chest leads will be assessed (e.g. V4 is expected to be assigned to bV4)
Heart rhythm1 hourECGs will be assessed for rhythm (eg. sinus rihythm, atrial fibrillation) by two board certified cardiologists
Ventricular depolarisation abnormalities1 hourECGs will be assessed for ventricular depolarisation abnormalities (eg. bandle branch blocks) by two board certified cardiologists
Ventricular repolarisation abnormalities1 hourECGs will be assessed for ventricular repolarisation abnormalities (eg. ST elevation) by two board certified cardiologists

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026